Novavax commences Phase 2 clinical trial of COVID-19 vaccine candidate
Trial to enroll up to 1,500 volunteers in the US and Australia, with approximately 50 per cent between 60 and 84 years of age
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
NVX-CoV2373
UK signs deals with J&J, Novavax for COVID-19 vaccine supplies
The latest agreements bring Britain’s total number of doses secured to 362 million for a population of 66 million
Novavax announces collaboration with SK bioscience for COVID-19 vaccine
SK bioscience will manufacture the vaccine antigen component for use in the final drug product globally during the pandemic period